Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Xilio Therapeutics (XLO) Leases (2024 - 2025)

Historic Leases for Xilio Therapeutics (XLO) over the last 2 years, with Q3 2025 value amounting to $4.1 million.

  • Xilio Therapeutics' Leases fell 1277.23% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 million, marking a year-over-year decrease of 1277.23%. This contributed to the annual value of $4.6 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Xilio Therapeutics reported Leases of $4.1 million as of Q3 2025, which was down 1277.23% from $4.3 million recorded in Q2 2025.
  • Over the past 5 years, Xilio Therapeutics' Leases peaked at $5.0 million during Q1 2024, and registered a low of $4.1 million during Q3 2025.